Skip to main content
Clinical Trials/TCTR20230516004
TCTR20230516004
Recruiting
Phase 4

Effectiveness and Safety of Platelet-Rich Plasma in Restoration of the Skin in Periorbital Areas, Frontal Hairline, and Eyebrows

ASTRACO MEDICAL NETWORKS LTD.0 sites15 target enrollmentMay 16, 2023

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Androgenetic Alopecia at hairline with mild to moderate wrinkle at periorbital
Sponsor
ASTRACO MEDICAL NETWORKS LTD.
Enrollment
15
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 16, 2023
End Date
May 21, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ASTRACO MEDICAL NETWORKS LTD.

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 35\-65 years
  • 2\. Both men and women
  • 3\. Mild to advanced photoaging by Glogau classification group I\-III
  • 4\. Androgenetic Alopecia by dermoscopic criteria

Exclusion Criteria

  • 1\.Pregnancy or lactation
  • 2\.Participants with using cream that affect wrinkle or colors or with antioxidant ingredients within 1 month before joining research
  • 3\.Participants with treatment like laser, filler or botulinum toxin injection within 3 month before joining research
  • 4\.Participants with history of low platelet or coagulopathy or taking medicine that interfere the coagulation like warfarin
  • 5\.Participants with needle phobia
  • 6\.Participants with history of allergy to anesthesia drug or sodium citrate
  • 7\.Participants with underlying disease of connective tissue diseases, autoimmune disease, immunosuppressive host or kelod
  • 8\.Participants with any psychological problem

Outcomes

Primary Outcomes

Not specified

Similar Trials